LXEO Smart Money
Lexeo Therapeutics, Inc. Common Stock
1W: -2.2%
1M: -18.4%
3M: -38.5%
YTD: -71.9%
1Y: -70.0%
$2.87
+0.17 (+6.30%)
After Hours: $3.03 (+0.16, +5.57%)
Weekly Expected Move ±11.6%
$2
$2
$3
$3
$3
Credit Risk of going bust: lower than 55% of companies Debt: 3.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.6%), Lexeo Therapeutics, Inc. Common Stock would be worth roughly what it owes.
Total debt $6.8M against a stock market value of $221.6M.
Distance to default 5.64 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.4M (short-term plus half of long-term), stock volatility 71.7%; Altman Z'' 9.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.6%), Lexeo Therapeutics, Inc. Common Stock would be worth roughly what it owes.
Total debt $6.8M against a stock market value of $221.6M.
Distance to default 5.64 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.4M (short-term plus half of long-term), stock volatility 71.7%; Altman Z'' 9.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026167
Institutions Holding
+3 vs prior
185.6%
Ownership
-21.25%
30
New
59
Increased
61
Reduced
22
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Townsend Richard Nolan | officer: chief executive officer | A-Grant/Award | 2,306 | $2.64 | $6K | Filing |
| 2026-09-14 | Otero Jose Manuel | officer: chief operating officer | A-Grant/Award | 2,110 | $2.64 | $6K | Filing |
| 2026-09-14 | Bhalla Narinder Pal | officer: chief medical officer | A-Grant/Award | 2,714 | $3.58 | $10K | Filing |
| 2026-08-18 | Tamayo Louis Edward | officer: chief financial officer | S-Sale | 4,117 | $4.91 | $20K | Filing |
| 2026-08-18 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 1,304 | $4.96 | $6K | Filing |
| 2026-08-18 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 3,345 | $4.95 | $17K | Filing |
| 2026-07-01 | Tamayo Louis Edward | officer: chief financial officer | S-Sale | 4,641 | $4.49 | $21K | Filing |
| 2026-07-01 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 4,666 | $4.48 | $21K | Filing |
| 2026-07-01 | Bhalla Narinder Pal | officer: chief medical officer | S-Sale | 22,306 | $4.42 | $99K | Filing |
| 2026-07-01 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 25,947 | $4.48 | $116K | Filing |
| 2026-06-29 | Tamayo Louis Edward | officer: chief financial officer | A-Grant/Award | 12,000 | $— | $0 | Filing |
| 2026-06-29 | Otero Jose Manuel | officer: chief operating officer | A-Grant/Award | 12,060 | $— | $0 | Filing |
| 2026-06-29 | Bhalla Narinder Pal | officer: chief medical officer | A-Grant/Award | 55,000 | $— | $0 | Filing |
| 2026-06-29 | Townsend Richard Nolan | officer: chief executive officer | A-Grant/Award | 67,000 | $— | $0 | Filing |
| 2026-05-18 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 1,302 | $5.07 | $7K | Filing |
| 2026-05-18 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 3,342 | $5.06 | $17K | Filing |
| 2026-04-06 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 55,000 | $5.69 | $313K | Filing |
| 2026-03-13 | Townsend Richard Nolan | officer: chief executive officer | A-Grant/Award | 2,623 | $2.64 | $7K | Filing |
| 2026-03-13 | Otero Jose Manuel | officer: chief operating officer | A-Grant/Award | 5,930 | $2.64 | $16K | Filing |
| 2026-02-18 | Otero Jose Manuel | officer: chief operating officer | S-Sale | 3,016 | $6.40 | $19K | Filing |
| 2026-02-18 | Townsend Richard Nolan | officer: chief executive officer | S-Sale | 10,173 | $6.38 | $65K | Filing |
| 2026-02-13 | Bhalla Narinder Pal | officer: chief medical officer | A-Grant/Award | 49,500 | $— | $0 | Filing |
| 2026-02-04 | Otero Jose Manuel | officer: chief operating officer | A-Grant/Award | 65,000 | $— | $0 | Filing |
| 2026-02-04 | Tamayo Louis Edward | officer: chief financial officer | A-Grant/Award | 44,665 | $— | $0 | Filing |
| 2026-02-04 | Townsend Richard Nolan | officer: chief executive officer | A-Grant/Award | 161,665 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 6,384,200 | $30M | +5,134,200 | 2026-06-30 | Filing |
| Affinity Asset Advisors, LLC | 5,807,611 | $27M | +757,400 | 2026-06-30 | Filing |
| BlackRock, Inc. | 5,739,455 | $27M | +628,584 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 5,000,000 | $23M | — | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 4,824,725 | $22M | +400,000 | 2026-06-30 | Filing |
| STATE STREET CORP | 4,354,757 | $20M | +786,515 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 4,320,000 | $20M | -155,000 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 4,175,382 | $19M | -2,008,752 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 3,954,691 | $18M | +3,954,691 | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 3,947,850 | $18M | +345,400 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 3,898,570 | $18M | +63,571 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,125,893 | $15M | +118,800 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 2,833,622 | $13M | +1,220,842 | 2026-06-30 | Filing |
| Woodline Partners LP | 2,500,532 | $12M | -250,000 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 2,412,742 | $11M | +823,157 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,149,612 | $10M | +199,727 | 2026-06-30 | Filing |
| 683 Capital Management, LLC | 1,875,000 | $9M | +675,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,747,959 | $8M | +234,182 | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 1,565,950 | $7M | +98,600 | 2026-06-30 | Filing |
| Avoro Capital Advisors LLC | 1,489,189 | $7M | -385,811 | 2026-06-30 | Filing |